Literature DB >> 23505300

Preoperative assessment of high-risk candidates to predict survival after heart transplantation.

P Christian Schulze1, Jeffrey Jiang, Jonathan Yang, Faisal H Cheema, Kenneth Schaeffle, Tomoko S Kato, Maryjane Farr, Susan Restaino, Mario Deng, Mathew Maurer, Evelyn Horn, Farhana Latif, Paolo C Colombo, Ulrich Jorde, Nir Uriel, Jennifer Haythe, Rachel Bijou, Ron Drusin, Sun Hi Lee, Hiroo Takayama, Yoshifumi Naka, Donna M Mancini.   

Abstract

BACKGROUND: Alternate waiting list strategies expand listing criteria for patients awaiting heart transplantation (HTx). We retrospectively analyzed clinical events and outcome of patients listed as high-risk recipients for HTx. METHODS AND
RESULTS: We analyzed 822 adult patients who underwent HTx of whom 111 patients met high-risk criteria. Clinical data were collected from medical records and outcome factors calculated for 61 characteristics. Significant factors were summarized in a prognostic score. Age >65 years (67%) and amyloidosis (19%) were the most common reasons for alternate listing. High-risk recipients were older (63.2±10.2 versus 51.4±11.8 years; P<0.001), had more renal dysfunction, prior cancer, and smoking. Survival analysis revealed lower post-HTx survival in high-risk recipients (82.2% versus 87.4% at 1-year; 59.8% versus 76.3% at 5-year post-HTx; P=0.0005). Prior cerebral vascular accident, albumin <3.5 mg/dL, re-HTx, renal dysfunction (glomerular filtration rate <40 mL/min), and >2 prior sternotomies were associated with poor survival after HTx. A prognostic risk score (CARRS [CVA, albumin, re-HTx, renal dysfunction, and sternotomies]) derived from these factors stratified survival post-HTx in high-risk (3+ points) versus low-risk (0-2 points) patients (87.9% versus 52.9% at 1-year; 65.9% versus 28.4% at 5-year post-HTx; P<0.001). Low-risk alternate patients had survival comparable with regular patients (87.9% versus 87.0% at 1-year and 65.9% versus 74.5% at 5-year post-HTx; P=0.46).
CONCLUSIONS: High-risk patients had reduced survival compared with regular patients post-HTx. Among patients previously accepted for alternate donor listing, application of the CARRS score identifies patients with unacceptably high mortality after HTx and those with a survival similar to regularly listed patients.

Entities:  

Keywords:  heart failure; prognosis; transplantation

Mesh:

Year:  2013        PMID: 23505300      PMCID: PMC4283202          DOI: 10.1161/CIRCHEARTFAILURE.112.000092

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  18 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010.

Authors:  Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Paul Aurora; Jason D Christie; Richard Kirk; Fabienne Dobbels; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2010-10       Impact factor: 10.247

2.  Left ventricular assist device destination therapy versus extended criteria cardiac transplant.

Authors:  Mani A Daneshmand; Keshava Rajagopal; Brian Lima; Nikta Khorram; Laura J Blue; Andrew J Lodge; Adrian F Hernandez; Joseph G Rogers; Carmelo A Milano
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

3.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

Authors:  Mandeep R Mehra; Jon Kobashigawa; Randall Starling; Stuart Russell; Patricia A Uber; Jayan Parameshwar; Paul Mohacsi; Sharon Augustine; Keith Aaronson; Mark Barr
Journal:  J Heart Lung Transplant       Date:  2006-09       Impact factor: 10.247

4.  Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.

Authors:  Tomoko S Kato; Aalap Chokshi; Parvati Singh; Tuba Khawaja; Faisal Cheema; Hirokazu Akashi; Khurram Shahzad; Shinichi Iwata; Shunichi Homma; Hiroo Takayama; Yoshifumi Naka; Ulrich Jorde; Maryjane Farr; Donna M Mancini; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2011-07-15       Impact factor: 8.790

5.  Results with expanded donor acceptance criteria in heart transplantation.

Authors:  A Forni; G B Luciani; B Chiominto; M Pizzuti; A Mazzucco; G Faggian
Journal:  Transplant Proc       Date:  2011-05       Impact factor: 1.066

6.  Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors.

Authors:  Kimberly N Hong; Alexander Iribarne; Berhane Worku; Hiroo Takayama; Annetine C Gelijns; Yoshifumi Naka; Val Jeevanandam; Mark J Russo
Journal:  Ann Thorac Surg       Date:  2011-06-17       Impact factor: 4.330

7.  Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT).

Authors:  Eric S Weiss; Jeremiah G Allen; George J Arnaoutakis; Timothy J George; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

8.  Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant.

Authors:  George J Arnaoutakis; Timothy J George; Jeremiah G Allen; Stuart D Russell; Ashish S Shah; John V Conte; Eric S Weiss
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01       Impact factor: 5.209

9.  Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.

Authors:  Mark J Russo; Ryan R Davies; Kimberly N Hong; Jonathan M Chen; Michael Argenziano; Alan Moskowitz; Deborah D Ascheim; Isaac George; Allan S Stewart; Mathew Williams; Annetine Gelijns; Yoshifumi Naka
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

10.  The University of California at Los Angeles heart transplantation experience.

Authors:  Jon A Kobashigawa; Hillel Laks; Grace Wu; Jignesh Patel; Jaime Moriguchi; Michele Hamilton; Gregg Fonarow; Michael Fishbein; Abbas Ardehali
Journal:  Clin Transpl       Date:  2005
View more
  8 in total

1.  Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.

Authors:  Maryjane Farr; James Mitchell; Matthew Lippel; Tomoko S Kato; Zhezhen Jin; Paul Ippolito; Lorna Dove; Ulrich P Jorde; Hiroo Takayama; Jean Emond; Yoshifumi Naka; Donna Mancini; Jay H Lefkowitch; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2014-12-23       Impact factor: 10.247

2.  Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy.

Authors:  Lakshmi Sridharan; Brian Wayda; Lauren K Truby; Farhana Latif; Susan Restaino; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Paolo C Colombo; Mathew Maurer; Maryjane A Farr; Veli K Topkara
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

3.  Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.

Authors:  Anuradha Lala; John C Rowland; Bart S Ferket; Annetine C Gelijns; Emilia Bagiella; Sean P Pinney; Alan J Moskowitz; Marissa A Miller; Francis D Pagani; Donna M Mancini
Journal:  JAMA Cardiol       Date:  2020-06-01       Impact factor: 14.676

Review 4.  Advanced therapies for end-stage heart failure.

Authors:  Jason N Katz; Sarah B Waters; Ian B Hollis; Patricia P Chang
Journal:  Curr Cardiol Rev       Date:  2015

5.  Towards a cardiac allocation score: a retrospective calculation for 73 patients from a German transplant center.

Authors:  Sebastian Claes; Michael Berchtold-Herz; Qian Zhou; Georg Trummer; Matthias Bock; Andreas Zirlik; Friedhelm Beyersdorf; Christoph Bode; Sebastian Grundmann
Journal:  J Cardiothorac Surg       Date:  2017-03-07       Impact factor: 1.637

6.  Patient-Related Preoperative Clinical Factors Influencing 1-Year Survival After Orthotopic Heart Transplantation - A Single Center Polish Experience.

Authors:  Agnieszka Kuczaj; Szymon Pawlak; Piotr Przybyłowski; Szymon Warwas; Joanna E Śliwka; Michał Zakliczyński; Tomasz Hrapkowicz
Journal:  Ann Transplant       Date:  2022-02-22       Impact factor: 1.530

7.  Pre-operative Machine Learning for Heart Transplant Patients Bridged with Temporary Mechanical Circulatory Support.

Authors:  Benjamin L Shou; Devina Chatterjee; Joseph W Russel; Alice L Zhou; Isabella S Florissi; Tabatha Lewis; Arjun Verma; Peyman Benharash; Chun Woo Choi
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-19

8.  Systemic inflammation in acute cardiorenal syndrome: an observational pilot study.

Authors:  Christoph Linhart; Christof Ulrich; Daniel Greinert; Stefanie Dambeck; Andreas Wienke; Matthias Girndt; Rainer U Pliquett
Journal:  ESC Heart Fail       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.